0000899243-21-032385.txt : 20210810
0000899243-21-032385.hdr.sgml : 20210810
20210810181749
ACCESSION NUMBER: 0000899243-21-032385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210806
FILED AS OF DATE: 20210810
DATE AS OF CHANGE: 20210810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Recknor Chris P
CENTRAL INDEX KEY: 0001850917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49908
FILM NUMBER: 211161372
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET
STREET 2: SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoDyn Inc.
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: CYTODYN INC
DATE OF NAME CHANGE: 20031114
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-06
1
0001175680
CytoDyn Inc.
CYDY
0001850917
Recknor Chris P
1111 MAIN STREET, SUITE 660
VANCOUVER
WA
98660
0
1
0
0
Chief Operating Officer
Common stock
2021-08-06
4
A
0
19384
0.00
A
686050
D
Non-qualified stock option (right to buy)
1.32
2021-08-06
4
A
0
1450000
0.00
A
2031-08-06
Common stock
1450000
1450000
D
Represents shares received in lieu of 50% of a cash incentive bonus paid for services performed during the fiscal year ended May 31, 2021, which may be paid (a) 100% in cash or (b) 50% in stock and 50% in cash, as determined by the issuer's compensation committee of the board of directors.
The option vests in three equal annual installments beginning on August 6, 2022.
/s/ Antonio Migliarese, Attorney-in-fact
2021-08-10